News

CanadaBis, aka Stigma Grow, touts innovation and cost cutting

Published on July 11, 2025 by Pat Bulmer

Photo: Contributed

A Calgary cannabis company says it is succeeding in a tough market thanks to cost cutting and new products.

Calgary-based CanadaBis (aka Stigma Grow) released three- and nine-month financial statements that show generally positive numbers.

“Our ability to achieve positive EBITDA (earnings before Interest, taxes, depreciation and amortization — a key financial marker) in this challenging market is a testament to our team’s dedication and our strategic focus on cost management and product innovation,” said CEO Travis McIntyre in a news release. EDITDA was $440,665 for the quarter.

The company touted the successful launch of a new line of diamond and keef-coated pre-rolls.

“Revolutionary” vape hardware will be introduced later this year, the company said.

The company cited belt-tightening as it presented many of its numbers:

— “CanadaBis achieved gross revenue of $5.5 million for Q3 2025, reflecting a strategic decision to delist marginally profitable SKUs (products) from provincial boards.”

— “Gross profit as a percentage of gross revenue increased by 6%, indicating a significant enhancement in operating efficiency.”

— “The company successfully reduced selling, general and administrative expenses (SG&A) to $1.4 million, a significant decrease of 30% from $1.8 million in the same period last year. This cost control initiative has been crucial in maintaining positive EBITDA levels.”

“CanadaBis continues to focus on optimizing its operations through input and manufacturing cost control, SKU rationalization, and effective inventory management,” the statement said.

Looking ahead: “The company is now evaluating opportunities to expand its offerings in flower sales and licensing its brands internationally, in addition to bulk extract sales.”